Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q1 FY26 Earnings Presentation
28 slides from Nath Bio-genes (india)'s earnings presentation, Jul 11, 2025
Slide 1: Exchange filing cover letter for unaudited results presentation
11th July 2025 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation on
Slide 2: Investor Presentation Q1 – FY26
Nath Bio-Genes (I) Ltd. Investor Presentation Q1 – FY26 www.nathbiogenes.com
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Competitive Positioning In A Tough Sector
Competitive Positioning In A Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Wheat, Maize & • Build a dream-product basket with Fodder Bajra superior and diversified products • Empower Stakeholders; Build long- • Build an Un-paralleled Supply Chain term, loyal, symbio
Slide 5: What Our Business Delivered In Last 8 Years
What Our Business Delivered In Last 8 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Mn) 1,178 CAGR 11% 3,623 1,917 480 275 128 FY18 FY25 FY19 FY25 Field Crops Vegetables 4
Slide 6: Tailor Made Products
Tailor Made Products Understand key farmer requirements based on deep market research. Develop products to suit various agri climatic conditions xc xc Focus on disease and pest resistance which automatically results in higher yield Stringent multistage trials before commercial development 5
Slide 7: Focused on R&D
1 R&D Team of experienced scientists and experts Focused on R&D 2 Prioritize Disease and Pest resistance breeding 3 Large and Diverse collection of Germplasm 4 Well Invested, DSIR recognized R&D Innovation Centres Produce Genetically Pure and Premium Quality 5 Seeds 6 Cold storage facilities, wareho
Slide 8: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Growing Business Product Excellence Differentiated Margin Expansion Customer Experience Strong Positions in Innovation and Expanding market Growing EBITDA important crops solution that drive reach through new margins through productivity and and innovative effic
Slide 9: Farming Community’s Testimonials
Farming Community’s Testimonials 8
Slide 10: Farmers on Khushi-27
& Farmers on Khushi-27 wate seeae frierht sun ait taeced e ste wrdet ait afear ed eaferé | at enoregett-27 & wot age € | | Te uot eelt-27 Ua denctar fivew 21 ]
Slide 11: Farmers on Golden-72
Farmers on Golden-72 { Tel tot Mesot-72 A ae aeye Jus fect eI Be Crol HDUH Yotee UT alot Sf ast aisTeata aft 3B felt | 2 ais Ge ate eat el - 1010 Wear, reTEst (3iifsem) Poo.ven.72 U ey NATH SEEDS”
Slide 12: Farmers on Super-27
te ee Farmers on Super-27 ram een ( mer arrerame-27 Het echt wee? | ’ Te gee et afoar satel fees #1 sere ast JOH a Haeced eich Ete eer aH rer att Alot Ge Sai WACATA eat & | | - Bidet, fae: aren (srencer) ATH SEEDS _ SUPER-27 3 —WaTH HYBRID BAJA SEEDS
Slide 13: Farmers on Alexander
Farmers on Alexander a onal felaten fetd-siclesise Um sieeced thes el py { sab ber wide ee el ale crest Ufeaent bh fee aft . Th e| Ta sa foe Ht afeen sox fect 2 ALEXANDER ey NATH SEEDS”
Slide 14: | Ba are il vat ve. 2561 CPs eft aite der dea et
| Ba are il vat ve. 2561 CPs eft aite der dea et CBT HOTS VET El Se Nee Ee ON wh sry were aie unotne 1 Ged cet ela | tearaot 2 Gel sel fest & aE et aioe Jun fiche (_-aUlet sera, aftemecor, faieT: sHeToT (sTeTeTE) ey NATH SEEDS”
Slide 15: Nath Seeds farmer testimonial
& NATH SEDs” ‘wel Bebe Ae UH Hace HUTA Maw 81 wa ead A ae are sus ech a fee ed et & Wid wectelter eet & Grevt carseat wT wmafagaaa.. lb NBC 1111 BG Il Coton yc ae wt agar Yeenaooy
Slide 16: Nath Seeds farmer testimonial
& NATH SEDs” ‘Hel wT ATsTeT Ae-27 UH HaeaeA asTeT e. seh fag the vd aga @ atte Jus aft Faeced facie &. Tat eer are fev aft TEvHIUgHIAMAe...
Slide 17: Testimonials: Akhand
—owwwewe Testimonials: Akhand Farmers on “Akhand” one Ht eds CoH aeceat Tae WaT e, fied wet sod Tee ciel ET eld e. Wel BE Ud Hage eel ch HUT cisa Ufedeot dh feie ugm e she sos exer aft FeCeeA. AKHAND (nt#-1312) & NATH SEDs”
Slide 18: Q1 & FY26 Performance
EE 2 = Q1 & FY26 8. eee PERFORMANCE
Slide 19: Key Business Highlights
Key Business Highlights • Cotton: Delivered robust performance with a volume growth of 16% QoQ, translating into a 21% increase in value QoQ. • Paddy: Reported a 9% increase in value QoQ despite a 5% reduction in volume, highlighting the company’s commitment towards hybridisation in paddy. Crop Perf
Slide 20: Key Financial Highlights – Q1 & FY26
Key Financial Highlights – Q1 & FY26 Q1FY26 Q1FY25 YoY Revenue ₹ 2,802 Mn ₹ 2,439 Mn 14.9% Gross Profit ₹ 1,438 Mn ₹ 1,210 Mn 18.9% EBITDA ₹ 389 Mn ₹ 371 Mn 5.0% Profits from Ordinary Business (Excluding extra ordinary items) ₹ 361 Mn ₹ 339 Mn 6.7% 19
Slide 21: Segmental Revenue Contribution
Segmental Revenue Contribution Q1FY26 Revenue Q1FY25 Revenue INR 2,802 Mn INR 2,439 Mn Others Others, 30% 30% Cotton, Cotton 40% 38% Paddy Paddy, 30% 32% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 20
Slide 22: Income Statement
Income Statement Particulars (INR Mn) Q1FY26 Q1FY25 %Change(YoY) FY25 FY24 %Change (YoY) Total Revenue 2,802 2,439 14.9% 3,623 3,326 9% Gross Profit 1,438 1,210 18.9% 2,289 1,991 15% Gross Margin (%) 51% 49.6% 63% 60% EBITDA 389 371 5.0% 523 504 4% EBITDA Margin (%) 14% 14.9% 14% 15% Depreciation 10
Slide 23: Appendix
APPENDIX 22
Slide 24: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6487 6,133 6,107 5,576 5,734 888 5,420 5,076 4,692 679 659 672 576 478 3,033 363 328 207 235 1,071 1,213 -121 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24
Slide 25: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Leadership Team Mr. Nandkishor Kagliwal Dr. Capt. Devinder Khurana Mr. Amol Gupta Chairman Executive Vice President CFO Dr. V. N. Kulkarni Mr. K. Reddy Mr. Harish Pandey Mr. Satish Kagliwal Head – R & D Head – Supply Chain Business Lead Managing Direc
Slide 26: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY25 FY24 FY23 FY22 FY21 Total Revenue 3,623 3,326 3,013 2,783 3,076 Gross Profit 2,289 1,991 1,667 1,544 1,715 Gross Margin (%) 63% 60% 55% 56% 56% EBITDA 523 505 489 373 667 EBITDA Margin (%) 14% 15% 16% 13% 22% Depreci
Slide 27: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn) FY25 FY24 FY23 FY22 FY21 Liabilities (INR Mn) FY25 FY24 FY23 FY22 FY21 Fixed Assets 2,430 2,406 2,340 2,329 2,333 Share Capital 190 190 190 190 190 Other Intangible 72 88 104 120 136 Assets Financial Assets 61 61 51 51 53 Reserves & Surplus 6,297 5,917 5,544
Slide 28: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+91 8451029510
Nath Bio-Genes (India) — Q1 FY26 Earnings Presentation on 6ix